Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay

Research in Social and Administrative Pharmacy

Volumn 13, Issue 2, 2017, Pages 378-388

  Aikin, Kathryn J ^a   Southwell, Brian G ^b   Paquin, Ryan S ^b   Rupert, Douglas J ^b   O'Donoghue, Amie C ^a   Betts, Kevin R ^a   Lee, Philip K ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Corrective advertising; Direct to consumer prescription drug advertising; Misinformation; Risk communication

Indexed keywords

ANTIOBESITY AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; CONSUMER HEALTH INFORMATION; CONTROLLED STUDY; DIRECT-TO-CONSUMER ADVERTIZING; DRUG INDUSTRY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RECALL; RISK; STANDARDS; TELEVISION; TIME FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-OBESITY AGENTS; CONSUMER HEALTH INFORMATION; DIRECT-TO-CONSUMER ADVERTISING; DRUG INDUSTRY; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; PRESCRIPTION DRUGS; RISK; TELEVISION; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 84969921305     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2016.04.004     Document Type: Article

References (25)

1. 1 Southwell, B.G., Thorson, E.A., The prevalence, consequence, and remedy of misinformation in mass media systems. J Commun 65 (2015), 589–595.
2. 2 O'Donoghue, A.C., Sullivan, H.W., Aikin, K.J., Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs. Ann Behav Med 48 (2014), 311–322.
3. 3 Schwartz, L.M., Woloshin, S., Welch, G., Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med 150 (2009), 516–527.
4. 4 Scammon, D.L., Semenik, R.J., Corrective advertising: evolution of the legal theory and application of the remedy. J Advertising 11 (1982), 10–20.
5. 5 Mazis, M.B., McNeill, D.L., Bernhardt, K.L., Day-after recall of Listerine corrective commercials. J Public Policy Mark 2 (1983), 29–37.
6. 6 Darke, P.R., Ashworth, L., Ritchie, R.J.B., Damage from corrective advertising: causes and cures. J Marketing 72 (2008), 81–97.
7. 7 Fintor, L., Direct-to-consumer marketing: how has it fared?. J Natl Cancer Inst 94 (2002), 329–331.
8. 8 Mazis, M.B., Ftc v. Novartis: the return of corrective advertising?. J Public Policy Mark 20 (2001), 114–122.
9. 9 Palumbo, F.B., Mullins, C.D., The development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J 57 (2002), 423–443.
10. 10 Singer, N., A Birth Control Pill that Promised Too Much. February 10, 2009, The New York Times B1.
11. 11 Aikin, K.J., Betts, K.R., O'Donoghue, A.C., et al. Correction of overstatement and omission in direct-to-consumer prescription drug advertising. J Commun 65 (2015), 596–618.
12. 12 Wilkie, W.L., McNeill, D.L., Mazis, M.B., Marketing's “scarlet letter”: the theory and practice of corrective advertising. J Marketing 48 (1984), 11–31.
13. 13 Kollath-Cattano, C.L., Abad-Vivero, E.N., Thrasher, J.F., et al. Adult smokers' responses to “corrective statements” regarding tobacco industry deception. Am J Prev Med 47 (2014), 26–36.
14. 14 Jacoby, J., Nelson, M.C., Hoyer, W.D., Corrective advertising and affirmative disclosure statements: their potential for confusing and misleading the consumer. J Mark 46 (1982), 61–72.
15. 15 Bernhardt, K.L., Thomas, C.K., Mazis, M.B., A field study of corrective advertising effectiveness. J Public Policy Mark 5 (1986), 146–162.
16. 16 Southwell, B.G., Barmada, C.H., Hornik, R.C., Maklan, D.M., Can we measure encoded exposure? Validation evidence from a national campaign. J Health Commun 7 (2002), 445–453.
17. 17 Schacter, D.L., Dobbins, I.G., Schnyer, D.M., Specificity of priming: a cognitive neuroscience perspective. Nat Rev Neurosci 5 (2004), 853–862.
18. 18 Southwell, B.G., Between messages and people: a multilevel model of memory for television content. Commun Res 32 (2005), 112–140.
19. 19 Singh, S.N., Mishra, S., Bendapudi, N., Linville, D., Enhancing memory of television commercials through message spacing. J Marketing Res 31 (1994), 384–392.
20. 20 Weeks, B., Southwell, B., The symbiosis of news coverage and aggregate online search behavior: Obama, rumors, and presidential politics. Mass Commun Soc 13 (2010), 341–360.
21. 21 Kassarjian, H.H., Carlson, C.J., Rosin, P.E., A corrective advertising study. Adv Consumer Res 2 (1975), 631–642.
22. 22 Smith, P., Bansal-Travers, M., O'Connor, R., et al. Correcting over 50 years of tobacco industry misinformation. Am J Prev Med 40 (2011), 690–698.
23. 23 Kirk, R.E., Experimental Design: Procedures for the Behavioral Sciences. 4th ed, 2013, Sage, Thousand Oaks, CA.
24. 24 Shadish, W.R., Cook, T.D., Campbell, D.T., Experimental and Quasi-experimental Designs for Generalized Causal Inference. 2002, Houghton Mifflin, Boston, MA.
25. 25 Hayes, A.F., Krippendorff, K., Answering the call for a standard reliability measure for coding data. Commun Methods Meas 1 (2007), 77–89.